Travere Therapeutics' Non Operating Income fell 40.37% to $783,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.5 million, marking a year-over-year decrease of 164.26%. This contributed to the annual value of -$3.3 million for FY2024, which is 127.59% down from last year.
According to the latest figures from Q3 2025, Travere Therapeutics' Non Operating Income is $783,000, which was up 248.86% from -$526,000 recorded in Q2 2025.
Over the past 5 years, Travere Therapeutics' Non Operating Income peaked at $5.7 million during Q4 2023, and registered a low of -$9.8 million during Q1 2022.
Moreover, its 3-year median value for Non Operating Income was $1.3 million (2024), whereas its average is $802,000.
Its Non Operating Income has fluctuated over the past 5 years, first soared by 405.31% in 2023, then plummeted by 267.71% in 2024.
Over the past 5 years, Travere Therapeutics' Non Operating Income (Quarterly) stood at -$3.9 million in 2021, then skyrocketed by 128.80% to $1.1 million in 2022, then soared by 405.31% to $5.7 million in 2023, then crashed by 209.34% to -$6.2 million in 2024, then crashed by 40.37% to $783,000 in 2025.
Its Non Operating Income stands at $783,000 for Q3 2025, versus -$526,000 for Q2 2025 and $1.5 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value